Galmed Pharmaceuticals Ltd. (GLMD) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Total Current Assets | 18.63M | 19.72M | 21.08M | 16.3M | 16.12M | 17.68M | 10.08M | 11.18M | 13.24M | 14.2M | 9.79M | 12.83M | 14.72M | 20.48M | 23.13M | 29.7M | 36.05M | 43.69M | 51.66M | 59.7M |
| Cash & Short-Term Investments | 18.16M | 19.05M | 20.53M | 15.73M | 15.33M | 17.14M | 9.82M | 10.93M | 12.76M | 13.31M | 9.33M | 12.15M | 13.79M | 19.21M | 22.4M | 28.74M | 34.81M | 41.91M | 51.06M | 58.8M |
| Cash Only | 3.98M | 3.31M | 4.96M | 4.77M | 4.65M | 9.72M | 1.84M | 1.58M | 2.98M | 1.48M | 1.01M | 1.67M | 2.02M | 4.06M | 1.98M | 3.74M | 2.88M | 3.49M | 7.92M | 13.38M |
| Short-Term Investments | 14.17M | 15.74M | 15.56M | 10.96M | 10.68M | 7.42M | 7.99M | 9.35M | 9.78M | 11.83M | 8.32M | 10.48M | 11.77M | 15.15M | 20.42M | 25M | 31.93M | 38.41M | 43.14M | 45.42M |
| Accounts Receivable | 80K | 549K | 433K | 447K | 209K | 426K | 135K | 254K | 165K | 770K | 341K | 568K | 157K | 1.15M | 614K | 843K | 79K | 1.67M | 487K | 784K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114.54K | 113.32K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 124K | 124K | 123K | 122K | 121K | 119K | 118K | 0 | 0 | 115K | 456 | 682 | 114K | 114K | 114K | 114K | 114K | 113K | 113K | 113K |
| Total Non-Current Assets | 0 | 1.86M | 1.86M | 2.39M | 2.38M | 3.27M | 3.27M | 3.34M | 3.39M | 3.44M | 3.49M | 1.96M | 1.84M | 391K | 445K | 497K | 551K | 606K | 660K | 675K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74K | 125K | 175K | 226K | 281K | 337K | 391K | 445K | 497K | 551K | 606K | 660K | 675K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 1.59M | 1.59M | 2.12M | 2.12M | 3.27M | 3.27M | 3.27M | 3.27M | 3.27M | 3.27M | 1.68M | 1.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 267K | 267K | 267K | 257K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 18.63M | 21.58M | 22.94M | 18.68M | 18.5M | 20.95M | 13.34M | 14.52M | 16.63M | 17.64M | 13.28M | 14.79M | 16.56M | 20.87M | 23.57M | 30.2M | 36.6M | 44.3M | 52.33M | 60.38M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 0.69% | 3.03% | 71.98% | 28.67% | 11.25% | 18.78% | 0.48% | -1.83% | 0.41% | -15.48% | -43.68% | -51.02% | -54.76% | -52.89% | -54.95% | -49.99% | -30.12% | -26.11% | -19.31% | -14.28% |
| Total Current Liabilities | 2.85M | 2.47M | 2.42M | 1.81M | 2.17M | 2.51M | 1.55M | 1.76M | 2.75M | 2.09M | 2.72M | 2.8M | 3.09M | 5.03M | 2.73M | 5.65M | 5.88M | 6.35M | 7.01M | 7.14M |
| Accounts Payable | 2M | 1.67M | 1.37M | 1.31M | 1.31M | 1.34M | 1.2M | 1.38M | 1.88M | 1.47M | 2.14M | 2.27M | 2.56M | 4.75M | 2.09M | 4.83M | 4.87M | 5.23M | 5.63M | 5.8M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 557K | 798K | 0 | 0 | 603K | 0 | 351K | 382K | 0 | 617K | 583K | 0 | 160K | 282K | 640K | 0 | 1.01M | 1.11M | 1.38M | 1.33M |
| Current Ratio | 6.55x | 7.98x | 8.71x | 9.02x | 7.42x | 7.03x | 6.48x | 6.34x | 4.81x | 6.79x | 3.59x | 4.58x | 4.76x | 4.07x | 8.48x | 5.26x | 6.13x | 6.88x | 7.37x | 8.37x |
| Quick Ratio | 6.55x | 7.98x | 8.71x | 9.02x | 7.42x | 7.03x | 6.48x | 6.34x | 4.81x | 6.79x | 3.55x | 4.54x | 4.76x | 4.07x | 8.48x | 5.26x | 6.13x | 6.88x | 7.37x | 8.37x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44K | 89K | 134K | 183K | 229K | 274K | 318K | 283K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44K | 89K | 134K | 183K | 229K | 274K | 318K | 283K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 2.85M | 2.47M | 2.42M | 1.81M | 2.17M | 2.51M | 1.55M | 1.76M | 2.75M | 2.09M | 2.72M | 2.8M | 3.14M | 5.12M | 2.86M | 5.83M | 6.11M | 6.62M | 7.33M | 7.42M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41K | 0 | 0 | 0 | 215K | 89K | 134K | 183K | 229K | 274K | 318K | 283K |
| Net Debt | -3.98M | -3.31M | -4.96M | -4.77M | -4.65M | -9.72M | -1.84M | -1.58M | -2.94M | -1.48M | -1.01M | -1.67M | -1.8M | -3.97M | -1.85M | -3.56M | -2.65M | -3.22M | -7.61M | -13.1M |
| Debt / Equity | - | - | - | - | - | - | - | - | 0.00x | - | - | - | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | -3.67x | - | - | - | - | -293.60x | - | - | -12.89x | - | -932.50x | -119.45x | -174.23x | - | - | - |
| Total Equity | 15.78M | 19.11M | 20.52M | 16.88M | 16.33M | 18.44M | 11.79M | 12.76M | 13.88M | 15.55M | 10.55M | 11.99M | 13.42M | 15.75M | 20.71M | 24.37M | 30.5M | 37.68M | 45M | 52.96M |
| Equity Growth % | -3.34% | 3.67% | 74.12% | 32.31% | 17.64% | 18.58% | 11.68% | 6.39% | 3.4% | -1.28% | -49.04% | -50.79% | -55.99% | -58.2% | -53.97% | -53.99% | -30.93% | -29.78% | -24.86% | -17.39% |
| Book Value per Share | 2.40 | 3.50 | 5.20 | 9.48 | 10.16 | 266.71 | 22.47 | 2.34 | 2.75 | 2.49 | 6.28 | 7.14 | 7.99 | 9.38 | 12.38 | 14.57 | 18.23 | 22.53 | 26.91 | 33.98 |
| Total Shareholders' Equity | 15.78M | 19.11M | 20.52M | 16.88M | 16.33M | 18.44M | 11.79M | 12.76M | 13.88M | 15.55M | 10.55M | 11.99M | 13.42M | 15.75M | 20.71M | 24.37M | 30.5M | 37.68M | 45M | 52.96M |
| Common Stock | 3.41M | 2.79M | 2.69M | 1.03M | 742K | 665K | 263K | 249K | 209K | 166K | 70K | 70K | 70K | 70K | 70K | 70K | 70K | 70K | 70K | 70K |
| Retained Earnings | -210.78M | -205.96M | -204.07M | -201.57M | -200.47M | -197.26M | -195.35M | -194.23M | -192.95M | -190.94M | -189.46M | -187.87M | -186.04M | -183.4M | -178.05M | -174.32M | -168.17M | -160.72M | -153.01M | -144.61M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -303K | -316K | -403K | -397K | -416K | -342K | -435K | -455K | -454K | -607K | -662K | -645K | -745K | -876K | -982K | -616K | -171K | -75K | 108K | 142K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |